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Abstract 
Purpose:  The Objective of this study is to ascertain that as the intensity of exercise 
increases through the stages of the Chester Step Test (CST) does the difference 
between the beta blocked(BB) and the non beta blocked(NBB) participants heart 
rate(HR) response increase.  
Methods:  The study utilised a repeated measures design. Twenty males with a 
mean age of 58.9 (±6.1) taking Beta Blocker medication completed the CST on two 
occasions within one week of another.  A further Seven males and thirteen females 
with mean age 61.5 (± 6.3) who were not taking Beta Blockers data from previous 
study data using the Chester  Step Test was used to compare the HR and Rating of 
Perceived Exertion(RPE) responses at each stage of the CST. Each stage of the 
CST lasted two minutes after which HR and RPE were collected until the participant 
achieved 80% of predicted Maximum Heart Rate or RPE 15. 
Results :HR was significantly different between the two groups at each stage of the 
CST p=<0.05. RPE was significantly different between the two groups at each stage 
of the CST p=<0.05. Limits of Agreement suggested test-re-test reliability of the CST 
for BB participants with the worse case HR being 11bpm above the mean in the final 
stage of the CST. 
Conclusions:   The data suggests that as intensity of exercise increases as does 
the difference between the BB and NBB HR response.  The data implies there may 
be some sex differences which will need investigating further.  RPE was shown to be 
significantly different between the two groups.  The data also showed that the CST is 
reliable for participants taking BB. 
Key words:, RPE- Rating of perceived Exertion, CST- Chester Step Test, BB – Beta 
Blocked NBB- Non Beta Blocked 
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1.0 Introduction 
1.1 Background 
Coronary heart disease (CHD) is the leading cause of mortality in the UK 
(www.heartstats.org).   However, since the 1970’s mortality rates for CHD 
have been falling (heartstats).  This increase in survival rate has been 
attributed in more than half the number of deaths to reductions in major risk 
factors such as smoking, physical inactivity and diet (Unal, Critchley & 
Capewell, 2004) and therefore emphasising the importance of education in 
these risk factors.  CHD is a complex disease process, although survival 
rates are increasing, if not treated appropriately it can have a major impact 
on an individual’s quality of life by effecting both physiological and 
psychological well being (Lear & Iganaszewski, 2001).  
 
The impact of CHD on people’s quality of life has led to a set of National 
Standards for the treatment of CHD (NSF, 2000).  One aspect of these 
standards is Cardiac Rehabilitation which is defined as a multi-disciplinary 
programme to relieve ongoing symptoms, prevent future cardiac events and 
to promote an individual’s return to a full and normal life (NSF, 2000).  
 
To achieve these standards many Cardiac Rehabilitation programmes now 
incorporate a comprehensive exercise programme within the Rehabilitation 
process (Schmid, 2005).  This has evolved from studies since the 1950s 
which have shown a decrease in mortality in those who became increasingly 
physically active following a cardiac event.  Prior to this the main prescription 
following myocardial infarction was six months of bed rest (BACR, 1995). 
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1.2 Exercise Prescription and HR  
Since this change in guidelines to incorporate exercise into cardiac 
rehabilitation, further emphasis has been placed on the correct intensity at 
which to prescribe exercise to be both safe and effective. 
Guidelines set by BACR (1995), ACSM (2006), AACVPR(2004) currently 
suggest a training intensity of 40-80% of Maximum Heart Rate (MHR) or 40-
70% Heart Rate Reserve (HRR).  These guidelines enable practitioners to 
prescribe safe and just as importantly effective exercise to patients.   
HR is used for exercise prescription due to research of over 100 years 
highlighting that it has a maximal value that can’t be surpassed despite 
increases in exercise intensity which mirrors the increase in cardiac output 
which is a much more invasive to measure (Roberg & Landwehr, 2002).  
Maximal heart can therefore be interpreted as the upper limit for an increase 
in central cardiovascular function (Roberg & Landwehr, 2002).  HR is also 
used for exercise prescription, as it is a marker of physiological strain on the 
skeletal muscles and with systolic blood pressure can be used as a marker 
of myocardial strain (Thow, 2006).  The ease of being able to monitor HR 
and its direct relationship with VO2 max is why HR has become the most 
commonly measured exercise response (Buckley, Holmes & Mapp, 1999) & 
(Astrand & Christensen, 1964). This relationship between HR and VO2 max 
allows for the same exercise prescription to be applied to all persons 
regardless of age or physical state.  
 
The method of calculating MHR for an individual has in recent research been 
questioned.  Since the 1930’s MHR has been shown to be approximately 
220 minus the individuals age and is the method that has been used to 
calculate a person’s predicted Max HR in all current exercise prescription 
guidelines.  Astrand, Astrand, Halback and Kilbom, (1973) however found 
the error of predicting max Hr from 220-age to have a standard deviation of 
+/-10bpm therefore meaning a person’s predicted max hr could be out as 
much as 20bpm above or below the age estimated MHR.  This is of a 
particular concern in cardiac populations as it could easily lead to over 
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prescribing a persons exercise and increasing the risk of ischemia or 
arrhythmia.  On the reverse this could also lead to many patients not 
achieving an effective Heart rate during exercise to cause positive 
physiological adaptations to occur within the body. A study by Karvonnen, 
Kentala and Mustala (1957) allowed for a more accurate relationship 
between %HRmax and VO2max by using the difference between HR at rest 
and HR on maximal exertion.  This is known as the HRR method.  This 
method also uses if an exact MHR cannot be used the 220-age method to 
calculate a predicted MHR leaving it also flawed. 
Londeree and Moeschberger, (1984) and Tanaka, Monahan, and Seals, 
(2001) found the method of 220-age to underestimate max HR in older 
populations therefore being quite relevant to the cardiac rehabilitation 
patients.  Robergs and Landwher, (2002) concluded in their review of 
literature relating to MHR that population specific formula should be used to 
predict maximal heart rate.  For the purpose of this study the Tanaka method 
was chosen to predict MHR. 
 
1.3 Exercise Prescription and Beta Blockers 
 
Issues can arise in prescribing exercise for patients on certain cardiac 
medications namely Beta blockers.   
Since the introduction of Beta Blockers in the 1960’s they have been one of 
the key medications for CHD patients, and now unless contraindicated are a 
standardised prescription (DOH, NSF 2000).  Beta blockers are one of the 
main medications to take into consideration when prescribing exercise due to 
their effect on the cardiovascular response to exercise.    Head, (1999), and 
Chapaluka Elbl, Nehyba, Tomaskova, and Jedlicka, (2005) stated the 
primary therapeutic effects of Beta Blockers are a reduction in resting blood 
pressure and resting heart rate and HR during exercise,  a reduction in 
myocardial oxygen uptake and a stabilising effect upon electrocardiographic 
abnormalities.  Both selective and non-selective Beta Blockers have a similar 
effect on the cardiovascular system reducing blood pressure, and heart rate 
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during both rest and sub-maximal exercise. Some studies of BB have shown 
BB to reduce exercising heart rate by 20-30% and cardiac output by 5-23% 
where as others have reported no change (Head,1999)  
1.4 RPE and Exercise Prescription. 
Due to the discrepancies that can occur when prescribing patients HR, RPE 
has also been used by many practioners to compliment THR.  Rating of 
perceived exertion is “the act of detecting and interpreting sensations from 
the body during physical exertion” (Noble & Robertson, 1996).  The use of 
RPE as a tool of exercise testing and analysis has become as widely 
accepted as HR as a marker of physiological intensity (Buckley, Holmes & 
Mapp, 1999).  RPE is commonly used in clinical settings to assess fitness 
and monitor prescription as safe and effective levels of exercise, physical 
activity or rehab purposes (Buckley & Eston 2007) 
1.5 Aim of Study 
 The aim of this study is to look at how Beta Blockers affect heart rate 
response during incremental exercise.  A group of participants taking Beta 
blockers will have their heart rate and rating of perceived exertion compared 
with an age match group to determine if the slope of the heart rate trend lines 
between beta blocked and non beta blocked participants are parallel, or does 
the difference increase as the intensity intensifies.  It will also be used to 
determine if participants taking beta blockers require like with other sub-
maximal tests a practice attempt. 
1.6 Hypotheses 
The difference between the beta blocked and non beta blocked participants 
heart rate will raise as the intensity of the exercise increases. 
Rating of perceived exertion (RPE) will be the same for both groups at the 
increasing exercise intensity. 
The Chester step test will not require a practice attempt for participants on 
Beta blockers. 
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2.0 Literature Review 
2.1 Exercise in Cardiac Rehabilitation 
Almost 200 years ago the first evidence for exercise as part of the treatment 
for Coronary heart disease arose.  Dr Heberden reported a patient who was 
suffering from chest pain, after sawing wood for 30 minutes each day had 
managed to alleviate his chest pain (Buckley, Spurway &Mclaren, 2008).  
Despite this finding, for many years Doctors continued to follow Thomas 
Hiltons “rest and pain” method and advocated up to 6 months prolonged rest 
for anyone who had suffered a myocardial infarction (Shephard & Balady, 
1999).  Since the 1960’s this treatment has been phased out and replaced 
with moderate to vigorous exercise for both the prevention of coronary heart 
disease and as a major part of the secondary treatment for those who have 
had angioplasty, coronary artery bypass grafts or a myocardial infarction ( 
Shephard & Balady, 1999). 
This change in practice has occurred as exercise has been shown to have a 
beneficial effect on several coronary heart disease risk factors.   
• Exercise has been shown to lower blood pressure for up to 12 hours 
post exercise (Pescatello, Fargo, Leach, & Scherzer, 1991). 
• Beneficial effects on glucose ,metabolism and insulin sensitivity ( 
Shephard &Balady,1999) 
• Physically active males and females have a more favourable waist hip 
ratio (<0.9) ( Troisi, Heinhold, Vokonas & Weiss, 1991) 
• Reduction in total cholesterol, LDL cholesterol and an increase in HDL 
cholesterol (Tran & Weltman, 1985). 
Regular cardiovascular or resistance training leads to specific changes in the 
muscular and cardiovascular systems that overall lead to an improvement in 
functional capacity.  For a healthy individual these changes consist of a 
decrease in heart rate at rest and at any given sub-maximal exercise 
intensity.  This is due to four main training adaptations – a stronger heart, 
more blood vessels around the muscles, better oxygen extraction by the 
muscles and more oxygen in the blood (Buckley, et al. 1999).  Studies have 
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shown that patients with CHD can have the same improvements (Balady, 
Fletcher, Froelicher, Hartley, Krauss, Obermann et al. 1994).  This training 
effect allows an individual to exercise at a higher work load with a lower heart 
rate (Shephard & Balady, 1999).  This training effect can be particularly 
beneficial for patients with CHD who have an ischemic threshold as they may 
be able to increase the amount they are able to do before reaching said 
threshold (Ehsani, Martin, Heath & Coyle, 1982, Thompson 2005).  
  
2.2 Physical Activity versus Physical Fitness 
Since the change in practice to encourage exercise post a cardiac event, 
there has been much debate as to whether being physically active or 
physically fit is required to produce the best benefits for cardiovascular 
health.  Physical activity is defined as any voluntary muscular movement that 
raises the energy demands of the body above resting (Buckley, et al. 1999).  
This differs from physical fitness which is defined by the ACSM “as the ability 
to perform moderate to vigorous levels of physical activity without undue 
fatigue and the capability of maintaining such ability throughout life” (ACSM, 
1990).  Both physical activity and fitness benefit cardiovascular health with 
positive effects on blood pressure, cholesterol levels, blood glucose, obesity 
and fibrinogen levels (Buckley et al.1999). 
One of the first studies to advocate the benefit of physical activity for the 
reduction of CHD was that published by Morris, Heady and Raffle (1953).  
The study compared bus conductors and bus drivers and there mortality 
rates from CHD.  The study found that the conductors who spent hours 
walking the length of the buses as well as up and down the stairs on the 
buses experienced half the CHD mortality rates as the drivers who would 
spend their entire day sitting (Morris et al. 1953). 
 
One of the key studies to suggest physical fitness through higher levels of 
physical activity to lower the risk of CHD was that by Sesso Paffenberger 
and Min Lee (2000).  Sesso et al. (2000) investigated the quantity and 
intensity of physical activity required for the primary prevention of CHD.  
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Through following 12,516 men they found males with multiple risk factors for 
CHD who expended in excess of 4200 kJ per week had a lower CHD risk 
than those expending less than 4200kJ. 
 
Shaper and Wannamethee, (1991) British regional heart study is another key 
study which highlighted as with the Sesso et al. (2000) study that those who 
engaged in higher levels of activity had a reduced incidence of CHD that was 
greater than the reduction in those who engaged in low levels of activity.  
Though the low levels of activity still showed a reduction in incidence of CHD 
compared to sedentary individuals.     
Williams (2000) conducted a meta- analysis of physical fitness and physical 
activity studies and risk of CHD. Williams, (2000) found that physical fitness 
and physical activity have significantly different relationships to CHD risk. 
Williams (2000) found that reductions in relative CHD risk are nearly twice as 
great for physical fitness as it is for physical activity.   
 
2.3 Physical Fitness for exercise prescription and long term mortality 
rate in CHD 
Exercise capacity and activity status have become well established 
predictors of Cardiovascular and overall mortality (Myers, Prakash, 
Froelicher, Partington & Atwood, 2002). With evidence for primary prevention 
of CHD suggesting the more activity that is engaged in at more vigorous 
levels, lowers the risk for CHD more than low levels of exercise.  Studies for 
secondary prevention of CHD have investigated the benefit of physical 
fitness for reduction in long term mortality. 
Kavanagh, Mertens, Hamm, Beyene, Kennedy, Corey et al. (2002) 
Examined the prognostic importance of maximal cardiopulmonary testing 
and found that exercise capacity was a powerful predictor of mortality more 
so than other established risk factors such as smoking and diabetes.  
Kavanagh et al. (2002) looked at exercise test data for 12,169 males with 
documented ischemic heart disease. Findings showed that a VO2 peak of 
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15-22 (4.3-6 Mets) resulted in a 38% decrease in risk of cardiac death but a 
VO2peak of >22 ml/kg per min an exercise capacity of > 6.3 Mets resulted in 
a 61% reduction in risk of cardiac death.  The findings of Kavanagh et al 
(2002) show that even a small exercise induced gain in aerobic power should 
thus make a major difference not only in functional capacity but also in 
survival prospects. 
Myers, et al. (2002) Investigated the exercise capacity of males referred for 
exercise testing and their mortality rates. This study differed from the 
Framingham study, and the aerobics centre longitudinal study in that it 
assessed 6213 males with and without documented cardiovascular disease.  
Results showed that exercise capacity is strong predictor of risk of death.    
The study found that with every 1 met increase in treadmill performance; this 
was associated with a 12% improvement in survival. Myers et al (2002) 
concluded like Kavanagh et al. (2002) that exercise capacity is an important 
prognostic factor in patients with cardiovascular disease.  The findings of 
Kavanagh et al. (2002) and Myers et al. (2002) are further supported by the 
earlier studies of Blair, Kohl, Barlow, Paffenberger, Gibbons and Macera 
(1995) who also observed a 7.9% reduction in mortality for every one minute 
increase in maximal treadmill time which can be roughly equated to 1 met as 
in the Myers et al (2002) study. 
Dorn, Naughton Imamura and Trevisan (1999) also examined whether a 
supervised exercise programme improved 19 year survival in male 
Myocardial Infarction patients. Dorn et al. (1999) also found each 1 met 
increase in work capacity from baseline to the end of the trial resulted in 
consistent reductions in all cause and Cardiovascular Disease mortality risk. 
The Studies all show that an improvement in physical fitness is key to long 
term survival.  Poor physical fitness is an easily modifiable risk factor and is 
commonly seen in patients on cardiac rehabilitation programmes.  
Improvements in fitness over time improve prognosis as highlighted by 
research over recent years. As exercise capacity is a strong and 
independent predictor of outcomes the literature supports the value of an 
exercise test as a clinical tool to obtain a patients level of physical fitness, as 
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its non-invasive, relatively inexpensive and provides a wealth of clinically 
relevant information. 
With research showing many benefits from exercise this has led to exercise 
guidelines for patients with CHD being created.  These guidelines for 
prescribing exercise to CHD patients suggest a training intensity of 40-80% 
of Maximum Heart Rate which should be taken from a maximal exercise test.    
The guidelines suggest the level is not too high so a patient is unable to 
obtain desired duration and clinical risk increases and that the level is not too 
low so a patient is unable to achieve their full health and clinical benefits 
(ACSM, 1994, BACR, 1995 and AACVPR, 2004).   
 
2.4 Importance of Exercise Prescription 
As with pharmacological therapy exercise also requires a prescription to find 
the most suitable dose with minimal side effects.  Exercise prescription is a 
key part of any patients care in cardiac rehabilitation.  The exercise must be 
pitched at a level below the patient’s ventilatory threshold as anything above 
this level could be potentially harmful for the patient (Tegtbur, Pethig, 
Machold, Haverich & Busse, 1986).  Training above a patient’s ventilatory 
threshold has been known to trigger, arrhythmia, ischemia, and thrombosis 
(Tegtbur et al. 1985, ACSM, 1994, BACR 1995).  On the other side an 
exercise programme that is to low in intensity may not be effective to 
produce the physiological benefits that exercise is known to produce for 
patients with CHD with particular reference to risk factor modification 
(Gossard, Haskell, Taylor, Mueller & Rogers, 1986 and Gordon & Scott, 
1995). 
 
Despite exercise prescription the risk of an adverse event during exercise 
does increase by as much as 16.9 fold during and immediately after exercise 
(Metkus, Baughman & Thompson, 2010 and Albert, Mittleman, Chee, Lee, 
Hennekens & Manson, 2000).  The risk is highest among sedentary patients 
who undertake vigorous exercise abruptly (Thompson, Franklin, Balady, 
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Blair, Corrado, & Estes et al. 2007).  Despite this increased risk during 
exercise the figures for the annual absolute risk of a cardiac event are small 
with an estimated 1 sudden death per 15-18,000 participants (Thompson et 
al. 2007).  The risks are therefore outweighed for most patients by the 
benefits that can be gained (Metkus et al. 2010).  The majority of the risks 
associated can be argued to be substantially reduced through appropriate 
exercise prescription for each individual patient. 
 
2.5 Need for Sub-maximal testing for Exercise Prescription 
The most important aspect of prescription to ensure safe exercise is to 
ascertain the correct target heart rate (THR) for each individual patient.  
Commencing a programme at the appropriate heart rate is vital for patients 
with CHD as high levels of catecholamine’s and metabolic acidosis are 
known to trigger an arrhythmia especially in the basis of patients with 
diseased myocardium (Schmid 2005).  Through fitness testing either 
maximally or sub maximally it allows practitioners to obtain a variety of 
information and to monitor a patients starting and completing fitness levels.    
Thompson (2005) stated that CHD patients should undergo symptom limited 
exercise testing to determine maximal HR which is in agreeance with the 
ACSM and BACR guidelines and exclude important ischemia, cardiac 
symptoms  or arrhythmias that may occur whilst a patient is exercising as 
stated by Schmid (2005), ACSM (1999), BACR (1995).  Fitness Testing 
therefore assists in exercise prescription by ensuring an appropriate training 
heart rate for each individual patient is obtained that will allow appropriate 
physiological adaptations to occur, and avoid the risk exercising at a heart 
rate that may induce a clinical cardiac event such as ischemia or arrhythmia 
(Mckardle, Katch & Katch 2001).  Schmid, (2003) argues that as most 
patients on cardiac rehabilitation programmes have been re-vascularised, 
there is little need for a maximal exercise test for the purpose of exercise 
prescription.  Although Maximal exercise testing is considered the gold 
standard for gaining information to prescribe exercise for an individual, it’s 
not practical for most cardiac rehabilitation departments to conduct.   There 
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is the ethical view that if a participant is not being assessed for the clinical 
determination of ischemia (due to symptoms), which is not the case with the 
majority of patients attending cardiac rehabilitation programmes, due to the 
high rate now of re-vascularised patients, then the test shouldn’t really be 
conducted as it can be quite stressful for the patients to be taken to their 
maximum.  
 
2.6 Chester Step Test 
The Chester Step Test (CST) is a multi-staged step test, which requires 
participants to step on to and off a low step at a rate set by a metronome 
beat. Every two minutes heart rate (HR) and Rating of perceived exertion 
level (RPE) are checked and recorded and then the stepping rate is then 
increased by 5 steps. The heart rate and RPE levels that are recorded are 
then used to predict subjects VO2max, (Sykes, 1998 and Sykes & Roberts, 
2004).The CST is highly flexible in nature, with ranging step heights and step 
rates and limited equipment required, (Buckley Sim, Eston, Hession, & Fox, 
2004).  
In order to prescribe exercise intensity it is often necessary to estimate a 
patient’s maximal oxygen uptake (VO2max) capability. However, in a clinical 
setting it is not feasible to directly determine VO2max as this may jeopardise 
patient safety, therefore sub-maximal exercise testing is required to estimate 
VO2max, (ACSM, 2006). 
The CST provides a valid and reliable estimation for aerobic capacity for 
healthy individuals (Sykes & Roberts, 2004). However, other research has 
highlighted that the CST’s reliability and validity for participants taking beta-
blocking medication must be further evaluated, (Buckley et al. 2004).  
Research has proven that taking beta-blocking drugs can significantly reduce 
maximal HR by as much as 20-30%, (Eston & Thompson, 1997).  The 
Chester step test is a possible valid alternative to the maximal exercise test 
to aid with exercise prescription for the purpose of assessing an individual’s 
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heart response to exercise and gaining an insight into the patients functional 
capacity in terms of MET’s achieved. 
 
2.7 Beta Blockers and Heart Rate 
Since the change in practice in the 1950’s to incorporate exercise 
programmes into patients’ rehabilitation together with the complex nature of 
CHD, exercise prescription is a key element to ensure safe and effective 
exercise (Schmid, 2005).  Issues can arise in prescribing exercise for 
patients on certain cardiac medications namely Beta blockers.   
Since the introduction of Beta Blockers in the 1960’s they have been one of 
the key medications for CHD patients, and now unless contraindicated are a 
standardised prescription (DOH, NSF 2000).  Beta blockers are one of the 
main medications to take into consideration when prescribing exercise due to 
their effect on the cardiovascular response to exercise.   Head (1999), and 
Chapaluka, Elbl, Nehyba, Tomaskova and Jedlicka (2005) stated the primary 
therapeutic effects of Beta Blockers are a reduction in resting blood pressure 
and resting heart rate and HR during exercise, a reduction in myocardial 
oxygen uptake and a stabilising effect upon electrocardiographic 
abnormalities.  Both selective and non-selective Beta Blockers have a similar 
effect on the cardiovascular system reducing blood pressure, and heart rate 
during both rest and sub maximal exercise. Some studies of BB have shown 
BB to reduce exercising heart rate by 20-30% and cardiac output by 5-23% 
where as others have reported no change (Head,1999)  
The first studies investigating the effect of BB on heart rate and Rating of 
perceived exertion (RPE) response appear to be around 1979.  Sjoberg 
Frankenhaeuser, and Bjurstedt, (1979) examined the effect of propanolol on 
healthy male subjects during five workloads on a cycle ergometer.  They 
found that heart rate was significantly reduced but that the decrease in heart 
rate did not affect their perceived exertion of the task, implying that heart rate 
is not a prominent indication for perceived effort during exercise.  This study 
only looked at healthy subjects and was only based on a single dose of beta 
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blocker, where as patients at cardiac rehabilitation programmes are long 
term users of beta blockers and the effect can vary over time as a person’s 
body adapts to the medication.   
Van Hawaarden Binkhorst, Fennis, and Van Laar (1979) carried out a trial of 
the non-selective Beta Blocker propanolol and the Beta selective Blocker 
metoprolol on hypertensive patients.  The participants were required to carry 
out moderate exercise which was based on heart rate being below 150bpm 
which was chosen at random with no clear definition as to why this figure 
was chosen. The study showed a significant difference in exercising heart 
rate between the placebo and when the patients were Beta Blocked.  The 
study showed an average of 30bpm between heart rate difference between 
placebo and Beta Blocked patients.  RPE was once again shown to not be 
effected by Beta Blockers.   
Peason, Banks, and Patrick (1979) studied the effect of a single dose of 
propanolol and metoprolol on cardiovascular responses to progressive 
exercise in healthy trained male subjects. They found an increase in RPE 
when the participants were taking the Beta Blocker , Joyner, Freund, Jilka, 
Hetrick, Martinez, Ewy et al (1986) suggested the reason for this may be 
related to trained individuals already have an increased stroke volume and 
decreased heart rate for a given exercise intensity, however they may be 
unable to tolerate a working at 50-60% under BB as their body is unable to 
cope with a further heart rate reduction as there stroke volume is unable to 
increase further to already previously being at almost maximum.  For this 
reason trained individuals may perceive this level of work much harder than 
an untrained individual also on BB.  In such cases this is likely to be linked to 
haemodynamic effects as well as any metabolic effects.   Another flaw with 
this study was only one dose of Beta Blockers was given to the participants 
where it can take up to 4 weeks to adapt to a dose of BB.  HR was during the 
study despite this flaw significantly reduced once again by an average of 
20bpm, though again the study does not look at specific heart rate intensity.   
A classic study by Davies and Sargeant (1979) created the trend lines that 
as exercising intensity increased HR between Beta blocked and non – Beta 
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Blocked participants  went up parallel  with an average of 20-40 bpm 
between the two groups heart rates at a given intensity and that RPE was 
unaffected by the Beta Blockers.   
Some more recent studies have shown similar findings to those raised 
previously but in patients with CHD rather than healthy individuals.  Lamont, 
Romito, Finkelhor, and Kalhan (1997) found in patients with Good left 
ventricular function and no residual ischemia Beta Blockers can reduce a 
persons maximal heart rate by 20-40bpm.   
One of the most recent studies to examine the effect of beta blockers on 
heart rate response for exercise prescription was Wosnich, Hofmann, 
Fruhwald, Kraxner, Hodl, Pokan et al. (2003) investigated the effect of Beta 
blockers on percentage heart rate max and heart rate reserve models, in 
healthy male subjects.  Wosnich et al. (2003) were concerned about the 
accuracy of exercise prescription based on MHR in patients on BB. They 
found that mean HR was significantly lower at rest -15bpmin the BB group 
compared to the placebo, as was the mean HR at the aerobic threshold and 
anaerobic threshold. The % MHR was significantly lower at the thresholds 
Aerobic threshold 60-64% respectively and anaerobic threshold 82-86% 
between BB participants and placebo, therefore when pts on BB are 
encouraged to exercise at 85% of MHR they may well be exercising above 
their anaerobic threshold if this figure has not been taken from a clinical 
exercise test.    Wosnich et al. (2003) went on to conclude that for patients 
on BB RPE should be used instead of %HRR to prescribe exercise or 
alternatively upper limits for %HRR should be lower for patients taking BB. 
The main flaws with this study were a small sample size of 10 people, and 
they were all healthy subjects. 
Although previous research has offered vital insight into the effect of Beta 
blockers on participants’ heart response during exercise, few studies have 
looked at the effect of BB on Heart rate response on participants with CHD 
and are of a more accurate age as to those seen most commonly on cardiac 
rehabilitation programmes. 
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One of a few studies to look at the effect of BB in participants with CHD was 
Liu, Brodie and Bundred (2004).  Liu et al. (2004) found parallel regression 
lines between BB and NBB participants HR during the modified Bruce 
protocol.  Suggesting no difference as the intensity of the exercise increased, 
this being in keeping with the findings of Davies and Sargeant (1979).  They 
also found when comparing HR and RPE to Borg Healthy people HR 
response to exercise slope that the slopes of the BB and NBB older persons 
were much less acute.  This finding further emphasises the importance of 
establishing HR and RPE relationships for the purpose of exercise 
prescription.  They concluded that Patients on BB require HR specific 
equations where as RPE was shown to be unaffected by BB with both 
groups showing the same RPE response during the modified Bruce. 
 
Tabet, Meurin, Teboul, Tartiere, Weber, Renaud et al. (2008) investigated 
the effect of BB on prescribing exercise for CHD patients from  HR achieved 
on a cardiopulmonary exercise test,  through HR driven exercise sessions 
and participants perception of exercise.  They found that prescribing exercise 
based on HR achieved at VT led to lower exercise intensity for the session 
compared to when the participants determined the exercise intensity based 
on their own feelings.  In the HR driven session participants rated the 
session at 10-11 on the Borg scale where as the participants’ perception 
sessions were perceived as more difficult but not exhausting.  They 
concluded that as the respiratory exchange ratio for the higher intensity 
sessions showed no involvement of the anaerobic system these sessions 
allowed for greater recruitment of the aerobic capacities and were therefore 
more effective. 
 
2.8 Rating of Perceived Exertion 
Every individual perceives exertion (Noble & Robertson 1996) from day to 
day tasks to active recreation levels of physical strain and exertion are 
indiscriminately subjected to psychophysical self appraisal (Borg, 1998). 
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The Rating of perceived exertion (RPE) scale was created by Gunner Borg 
(1968).  Borg proposed that the development of a universal rating scale that 
was both practical and accurate in measuring perceptual intensity was 
required (Borg, 1998, Buckley et al. 1999 and Buckley & Eston 2007).  The 
subjective scale created by Borg was designed to run parallel to 
physiological markers of physical effort (Noble & Robertson, 1996).  Buckley 
and Eston (2007) stated that using such a scale would enhance 
understanding of internal mechanisms that individuals use to interpret and 
then adapt physical exercise.  Noble and Robertson (1996) also found that a 
persons perception of physical exertion allows them to monitor feelings of 
exercise intensity by sensory feedback which therefore allows an individual 
to pace themselves appropriately during a specific bout of exercise. 
Buckley, Sim, Eston, Hession, and Fox. (2004) stated that as intensity 
increases the sensations of exertion become stronger and more apparent to 
an individual to the point where the activities start to feel difficult or physically 
challenging. 
 
2.9 Reliability of RPE 
Eston and Williams (1988) assessed reliability of RPE for prescribing 
exercise intensity. Sixteen healthy subjects attended four separate exercise 
sessions 5 to 7 days apart, reliability was constantly high between trials (0.8 
and greater ).  Eston and Williams therefore concluded RPE is a useful frame 
for the regulation of high levels of exercise intensity. The study found that 
small amounts of practice with the scale improve its applicability at lower 
levels of exercise. 
Robertson and Noble (1997) found that RPE is an effective means of 
representing an appropriate exercise intensity for patients attending cardiac 
rehabilitation programmes. 
Gutmann, Squires, Pollock, Foster, and Anholm (1981) compared patients 
RPE responses on an initial ETT and then in subsequent exercise sessions. 
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Gutmann et al. (1981) found that RPE was reliably related to HR during the 
exercise sessions. 
Buckley Sim and Eston (2009) is one of the most recent studies which 
investigates the reliability of RPE.  Buckley et al. (2009) compared RPE at 
the same exercise level intensity between an initial Exercise Tolerance Test 
that was performed within a mean of 12 days post myocardial infarction, and 
two subsequent gym sessions.  There was no significant difference found in 
HR between the three sessions.  They found RPE during the initial ETT to be 
significantly different P<0.008 between ETT and gym session 1 and the ETT 
and gym session 2.  Buckley et al (2009) findings suggested initial RPE 
ratings soon after MI on ETT are inflated compared to responses at the same 
treadmill work rate during two subsequent cardiac rehabilitation sessions, 
therefore concluding caution is advised in using RPE from an initial ETT to 
guide initial exercise prescription in patients.  Buckley et al. (2009) also 
looked at during this study the reliability of reproducibility of RPE. They found 
good reliability for RPE between the two gym sessions with only one 
participants RPE differing by <2 scale points.  These more recent findings by 
Buckley et al cast doubt on those earlier studies by Eston and Williams and 
Gutmann et al. 
 
2.10 RPE Beta Blockers and HR 
Buckley and Eston (2007) stated RPE acts as a concurrent or substitute 
marker of significant physiological responses brought about by varying 
intensities of exercise such as %MHR.  Literature has highlighted that an 
RPE of 14/15 corresponds to 80% of MHR and thus a feasible end point to 
any sub-maximal exercise test (Buckley et al 2004). 
 
Eston and Connelly (1996) stated the RPE scale has gained widespread 
acceptance for gaining a subjective estimate of work intensity and as a 
means of monitoring and regulating exercise intensity.  Eston and Connelly 
supported this statement with findings in their research of, high correlations 
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between HR and RPE in individuals on BB.  There was however some 
evidence in the study to suggest that RPE response is mediated at higher 
absolute work rates. Eston and Connelly (1996) stated that because BB 
caused a decrease in HR and cardiac output at rest and during exercise, a 
decrease in myocardial contractility and a decrease in coronary and muscle 
blood flow.  These effects can in turn initiate premature fatigue and 
apprehension in the exercising patient. Therefore RPE provides important 
information and may be used to increase the accuracy of monitoring and 
prescription of exercise intensity in the cardiac population. 
Eston and Thompson (1997) investigated the efficacy of Borgs RPE to 
predict maximal exercise levels to control exercise intensity in patients taking 
BB for hypertension.  There were two groups each made up of 10 men and 
10 women in the control group were subjects who had risk factors for CV 
disease but weren’t taking any medication.  In the treatment group 
participants were well established on the cardio-selective BB atenolol.  
Participants were required to carry out 2 sub-maximal exercise tests during 
which RPE was reported for each increment. In test one participants used 
RPE in estimation mode where they reported RPE at the end of each 
increment. During Test 2 participants used RPE in production mode where 
they regulated the work rate based on their perception of effort at four 
determined points on the RPE scale (9, 13, 15, and 17) 
Results showed no significant difference between maximal heart rate and 
maximal power output when predicted from the regression lines of RPE 
Versus HR and RPE versus power output during the estimation test.  
However the prediction of maximal power was lower in women in the control 
group and the treatment group when this was predicted from the effort 
production protocol (p<0.01). When Eston and Thompson further 
investigated the differences for females, it seemed that when women were 
requested to select an exercise intensity to correspond with a given RPE 
they became more conservative and tended to overestimate the exercise 
intensity that they selected. Thus RPE was high relative to the exercise 
intensity. This finding wasn’t just exclusive to females they also found When 
the BB group and the women were asked to exercise at a specific RPE they 
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underestimated the level of exercise resistance required or overestimated 
the RPE For a given work rate. 
Findings support a strong positive relationship between RPE, HR and work 
rate in these patients in both passive effort and active effort production 
protocols. Eston and Thompson advised caution, as prediction of maximal 
exercise levels may be lower when the effort production procedures are used 
particularly in females and BB patients. 
2.11 Summary 
In summary, the immediate and most obvious effects of BB are a reduction in 
competitive blocking of B adrenoreceptors.  Hence during sub-maximal 
exercise patients receiving BB can experience moderate to large reductions 
in heart rate of between 20 and 30% (Head, 1999).  A combination of BB and 
physical exercise is considered beneficial for patients with CV disease (NSF, 
DOH 2000).  Ideally appropriate exercise intensity prescription for patients 
receiving BB requires a known maximal HR, this is however difficult to 
determine from sub-maximal exercise due to the moderate to large 
reductions in HR.  Although BB treatment decreases MHR it does not alter 
the % of MHR and % of maximal oxygen uptake prescribed for exercise 
(Eston &Thompson, 1997). 
RPE is often applied during graded exercise testing to obtain a subjective 
estimation of exercise intensity and is an accurate predictor of functional 
capacity in healthy adults.  RPE has a strong relationship with HR oxygen 
uptake, minute ventilation, and other physiological variables within a wide 
range of healthy and clinical populations.  RPE can therefore be considered 
as the ideal compliment or substitute to HR for exercise prescription in 
clinical populations.  RPE can be used with confidence, of its safety and 
efficacy in CHD patients. 
The only caution to be extended to the use of RPE on participants with BB 
depends on the type of BB used. Non-selective BB are associated with 
greater muscle fatigue, increased peripheral resistance and greater 
reductions in maximal oxygen uptake (Eston &Thompson, 1997).  Cardio-
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selective BB are likely to cause less local muscle fatigue which is an 
important consideration when using RPE as  a means of regulating exercise 
intensity in these patients. 
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3.0 Methodology 
3.1Participants 
Twenty participants (all male) from the Countess of Chester Cardiac 
rehabilitation programme volunteered to take part in this study mean (SD) 
age58.9± 6.1. 
Participants were included by conforming to the following inclusion criteria: 
• Clinically stable (assessed by pre exercise health screen see 
appendix 1 ) 
• Taking Beta Blocking medication 
• Aged 50-65 
• Post Myocardial Infarction, Angioplasty or Coronary Artery Bypass 
Graft. 
Participants were excluded from the study based on the following exclusion 
criteria 
• Outside age bracket 
• Valve disease 
• Current arrhythmia 
• Ejection fraction of less than 40% 
• Neurological and physical/ mobility limitations that affect ability to 
carry out the Chester step test. 
• Blood Pressure systolic >200mmHg or diastolic 110mmHg 
• Acute systemic infection 
Data for a further 20 participants (7 Males and 13 Females) with a mean age 
of 61.5 (±6.3) who were not taking Beta Blockers was taken from a previous 
study.  The study had collected data on non beta blocked (with risk factors 
for coronary heart disease (CHD) but no confirmed CHD) individuals during 
the Chester step test. 
All participants were given a patient information sheet and  when they agreed 
to take part were given a date for testing where they would then  complete an 
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informed consent form and complete a pre test exercise screen to ensure 
they were suitable to complete the testing(See appendix1,2,3) 
Participants were tested at their usual cardiac rehabilitation session therefore 
avoiding the potential stress of attending a hospital environment for the test 
and not adding any extra journeys to the participants in the study. 
 
For this study to go ahead ethical approval was granted by NRES and 
Research and development at the Countess of Chester hospital. (See 
Appendix 4, 5) 
To ensure participant confidentiality all participants were allocated a number 
between one and forty. 
 
2.2 Experimental Design 
The study was designed to assess the relationship between beta blocked 
and non beta blocked HR responses to the Chester Step Test –a sub-
maximal incremental exercise test. The study was also designed to assess 
the validity and reliability of using the CST to assess HR and RPE response 
in beta blocked patients. 
The study used a repeated measures design, consisting of two testing 
sessions 1 week apart per participant.  All testing was performed at the 
Countess of Chester cardiac rehabilitation sessions in the fitness suite at the 
University of Chester. 
 
2.3 Exercise testing 
Each testing session consisted of 2 parts; present at all sessions was 
another member of the cardiac rehabilitation team who was also trained in 
immediate life support. 
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2.3.1 Part 1 Measurements taken on arrival 
On arrival at the cardiac rehabilitation session, participants were asked to sit 
on a chair and rest for 10 minutes, to ensure a more accurate resting heart 
rate (RHR) was achieved prior to the test commencing.  During this seated 
period on the first session participants were required to complete the 
informed consent and pre- test health screen.  The answers given in the 
health screen allowed participants to be checked that they were suitable to 
participant in the test, namely by taking their prescribed medications and not 
having any symptoms of chest pain or shortness of breath in the last week. 
After the 10 minute rest period participants RHR was taken through a radial 
pulse check for 15 seconds which also allowed for basic screening of any 
potential new onset of arrhythmia.  Blood pressure was checked using an 
automated sphypgmanometer on the participants left arm, unless there was 
a clinical reason as to why the left arm could not be used.  By checking the 
participants’ Blood pressure it ensured no participant had a blood pressure 
that day that would exclude them from taking part.  Participants predicted 
Maximal HR was determined from the Tanaka equation 207- (0.7*age) = 
MHR equation - 30 bpm for BB participants.  The participants 80% of MHR 
was then generated, as a test termination point. 
 
2.3.2 Part 2: Chester Step Test. 
Each participant was required to complete the multistage CST once using 
the 0.15m adapted step. This step height was chosen on the 
recommendations of Buckley et al 2004 who stated that as the cardiac 
population have a decreased exercise tolerance the lower step will allow 
more of the test to be completed before an RPE of 15 or 80% MHR is 
achieved, therefore enhancing the amount of data collected. 
Prior to the test commencing participants were fitted with a polar heart 
monitor to allow HR to be monitored.  The participants were then given the 
following standard instructions on using the RPE scale. 
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• Anchoring of the top and bottom ratings to previous experiences of no 
exertion at all and maximal effort. 
• Ensuring they were aware that they were giving an overall rating of 
the exertion incorporating physical, muscular and cardio-respiratory 
sensations. 
• That there was no right or wrong answer 
• That they could report their RPE at any stage during the test to ensure 
participant comfort. 
• That the scale would be in full view at all times during the test 
Participants then listened to the instructions for the Chester Step Test from 
the CST CD.  Participants were then required to step on to and off the step at 
a rate set by the metronome beat from the CST CD.  The test started at a 
pace of 15 steps per minute and increased by 5 steps per minute every 2 
minutes up to a maximum of 35 steps per minute in the final stage. 
At the end of each stage RPE was collected using Borgs 6-20 RPE scale 
and HR using polar HR monitors at the end of each stage until an RPE of 15, 
80% of predicted MHR.   The exercise test would also be stopped if any of 
the following were reported. 
• Chest Pain 
• Excessive shortness of breath( participant is unable to speak) 
• Unable to keep up with the pace of the test 
• Participant requested the test to be terminated 
As the test was sub-maximal participants weren’t being asked to work any 
harder than they would do in their usual cardiac rehabilitation session. 
 
2.4 Statistical Analysis 
The mean HR and RPE for each group at each stage of the Chester Step 
test were used to provide the basis for analysis.  Analysis was completed 
using SPSS V.17 and Excel. 
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Linear regression analysis was performed using the equation y=steepness of 
slope and x the point of intercept of the y axis.  By using this analysis it would 
allow form comparison of the steepness of the slopes between the BB and 
the NBB HR and RPE data.  
 
Interaction between the groups and stage of the Chester Step Test was 
analysed using a mixed model ANOVA. For the mixed model ANOVA to be 
conducted the following assumptions were required to be met, Data is 
normally distributed and the data has homogeneity of variance.  As there are 
less than 100 participants Shapiro-Wilk analysis is checked for normal 
distribution with a significance value of >0.05 required to pass the 
assumption.  For Homogeneity of variance to be assessed Levenes statistic 
was consulted with a significance value of >0.05 required to meet the 
assumption.  The interaction effect between the groups over the stages of 
the Chester Step Test would provide the p value.  For this analysis a p value 
of <0.05 was used to imply statistical significance. 
 
Independent t–tests were chosen to investigate at exactly which stage of the 
Chester Step Test significant differences between the two groups data were.  
The assumptions of normal distribution and homogeneity of variance were 
required to be met to continue with the t-test.  This was assessed through the 
Shapiro-wilk and Levene statistic as with the mixed model ANOVA.  For the 
results of the t-test to be classed as significant a p value of <0.05 was used.  
 
Limits of Agreement (L.o.A) was chosen to assess reliability for both HR 
between test 1 and 2 and RPE between test 1 and 2 for the BB participants 
data.  L.o.A was chosen as Lamb, (1998) suggested the Pearson correlation 
co-efficient is incorrect as the correlation is not sensitive to changes in the 
means of the two scores. Bland and Altman, (1986) also advocate the use of 
L.o.A due to its more complete appraisal of reliability.  L.o.A uses data from 
95% of subjects allowing therefore for extreme outlying data to be ignored in 
analysis. 
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4.0 RESULTS 
4.1 Participants Overview 
Twenty participants volunteered for the current study, all of whom completed 
the Chester Step test twice. Twenty further participants’ data was used from 
a previous study to provide the non beta blocked participants’ data.  As Table 
4.1 shows the data for stage 5 from the non Beta blocked participants is 
minimal therefore for the purpose of data analysis between the two groups 
only data collected from the first 4 stages of the Chester step test will be 
used.  In observation to table 4.2 it can be noted that the Beta Blocked 
participants have the physiological characteristics that would be expected of 
participants on BB with a mean lower systolic and diastolic Blood pressure 
117mmHg and 75 MmHg respectively and a lower mean Resting HR of 
60bpm. 
Table 4.1   Number of participants who completed each stage of the Chester Step 
Test   
Participants CST Stage1 CST Stage2 CST Stage 3 CST Stage 4 CST Stage5
Test 1 2 1 2 1 2 1 2 1 2
BB 20 20 20 20 20 20 19 19 18 18 
NBB 20 20 20 20 17 17 11 13 5 6 
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Table 4.2 General information of participants (mean±SD) 
Group 
 
 
N Sex Age Height 
(M) 
Weight 
(kg) 
BMI Systolic 
BP 
(mmHg) 
Diastolic BP 
(mmHg) 
RHR 
(bpm) 
BB 
 
20 20 M 58.9 
±6.1 
1.8 
±0.07 
91.0 
±15.4 
28.9 
±5.5 
117 
±14 
 
75 
±11 
 
60 
±11 
NBB 
 
20 7 M 
13 F 
61.5 
±6.3 
 
1.71 
±0.10 
70.9 
±8.6 
24.2 
±2.5 
136 
±23 
 
88 
±11 
 
74 
±12 
 
4.2 Analysis of Heart Rate Data 
 
Fig 4.1 Test 1 - Comparison of HR at each stage of Chester Step Test 
 
Fig 4.2 Test 2- Comparison of HR at each stage of Chester Step Test 
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Table 4.3 – Independent t-test findings for HR at each stage of Chester Step Test 
 Stage1 Stage2 Stage3 Stage4 
Test  1 2 1 2 1 2 1 2 
BB 80 ±11 78 ±11.2 86 ±10.9 85 ±10.9 92 ±10.7 92 ±10.8 98 ±12.3 98 ±11.1 
NBB 98±12 97±11 103±26 107±12 116±14 116±12 128±17 130±15 
Difference 
mean 
18 19 17 22 24 24 30 32 
P value P=0.000 P=0.000 P=0.012 P=0.000 P=0.000 P=0.000 P=0.000 P=0.000 
Figure 4.1 shows the steepness of the slopes between the BB and Non BB 
participants HR at each stage of the Chester Step Test during test 1.  The 
steepness of the Non BB participants slope is greater than the Beta Blocked 
slope where y=10.3 and y=6 respectively, therefore suggesting a difference 
in Hr as the intensity increases. When looking at the mean differences 
between the groups at each stage of the test table 4.3, this shows a gradual 
increase in the difference in the mean as the intensity of the exercise 
increased through the stages. Further analysis via the mixed model ANOVA 
revealed significant differences exist between the groups data with p≤0.05.  
To find where the actual differences were between the groups independent t-
test were run for each stage of the Chester Step test.  The T-test found 
significant differences between the HR’s of the two groups at all stages of the 
Chester Step test p=≤0.05. The t-test findings are summarised in table 4.3 
Figure 4.2 shows the steepness of the slope between the BB and NBB 
participants in the second trial of the Chester Step Test. Once again the 
slope is steeper for the Non BB participants compared to the BB participants 
where y=10.8 and 6.7 respectively.  A mixed model ANOVA was conducted 
to see if there was any significant difference between the 2 groups which 
once again found a significant difference in the data between the groups with 
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p≤0.05.  Independent t-test was again conducted to find exactly where the 
differences between the two groups were.  Again the t-test showed a 
significant difference between the 2 groups at all stage of the Chester Step 
test p=≤0.05.  The t-test findings are summarised in table 4.3 
4.3 Analysis of male only data for HR  
 
Fig 4.3.Test 1 - Comparison of HR at each stage of Chester Step Test for male 
participants  
 
Fig 4.4 Test 2 - Comparison of HR at each stage of Chester Step test for male 
participants  
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Table 4.4 Independent t-test findings for HR at each stage of Chester Step Test 
 Stage1 Stage2 Stage3 Stage4 
Test 1 2 1 2 1 2 1 2 
BB 80 ±11 78 ±11.2 86 ±10.9 85 ±10.9 92 ±10.7 92 ±10.8 98 ±12.3 98 ±11.1 
NBB 95±11.5 94±12.1 107±19 104±16.4 111±15.6 110±14.4 116±14.4 124±15.8 
Difference 
mean 
15 16 21 19 19 18 18 26 
P value P=0.005 P=0.004 P=0.003 P=0.002 P=0.004 P=0.004 P=0.019 P=0.000 
 
Figure 4.3 shows the steepness of the slopes between the BB and Non BB 
for the male participants HR at each stage of the Chester Step Test.  The 
steepness of the Non BB participants slope is greater than the Beta Blocked 
slope where y=6.7 and y=6 respectively. The difference in the slopes is much 
smaller that the slopes for the male and female combined data in fig 4.1 and 
fig 4.2, suggesting no increased difference in HR as the intensity increases.  
When looking at the mean differences between the groups at each stage of 
the test table 4.4, shows the mean difference between the groups HR for 
each stage of the Chester Step test to be very similar as the intensity was 
increased which differs from the results above with the gradual increase 
difference in the means as the intensity increased.   Further analysis via the 
mixed model ANOVA still revealed significant differences exist between the 
groups data with p=≤0.05.  To find where the actual differences were 
between the groups independent t-test were run for each stage of the 
Chester Step test.  The T-test found significant differences between the HR’s 
of the two groups at all stages of the Chester Step test p=≤0.05. The t-test 
findings are summarised in table 4.4 
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Figure 4.4 shows the steepness of the slopes between the BB and Non BB 
male participants HR at each stage of the Chester Step Test for test 2.  The 
steepness of the Non BB participants slope is greater than the Beta Blocked 
slope where y=9.6 and y=6.7 respectively.  This finding is in keeping with the 
slopes in fig 4.1 and 4.2.  When looking at the mean differences between the 
groups at each stage of the test table 4.4 shows a similar difference in the 
mean through stages 1-3 before a marked increase in the mean difference in 
stage 4.  Further analysis via the mixed model ANOVA revealed significant 
differences exist between the group’s data with p≤0.05.  To find where the 
actual differences were between the groups independent t-test were run for 
each stage of the Chester Step test.  The T-test found significant differences 
between the HR’s of the two groups at all stages of the Chester Step test 
p=≤0.05. The t-test findings are summarised in table 4.4. 
 
4.4 Analysis of %HRR data 
 
Fig 4.5 Test 1- Comparison of %HRR at each stage of Chester Step Test  
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Fig 4.6 Test 2 - Comparison of %HRR at each stage of Chester Step Test 
 
 
Table 4.5 Mean data for %HRR at each stage of Chester Step Test 
 Stage1 Stage2 Stage3 Stage4 
Test 1 2 1 2 1 2 1 2 
BB 25.5±10.3 23.3±9.8 34.6±11.1 33±10.5 42.8±11 42.4±11.6 51.5±14.9 50.8±13.7 
NBB 41.8±14.2 38.5±12.5 59.2±20.6 56.5±17.5 73.5±21.9 71.3±16.4 90.4±23.5 92.9±21.1 
Differenc
e mean 
16.3 15.2 24.6 23.5 30.7 28.9 38.9 42.1 
 
When comparing fig 4.5 test 1 %HRR and fig 3.6 test 2 %HRR data the 
steepness of the slopes are greater than the slopes for actual HR at each 
stage of the test as seen in fig 4.1- fig 4.4.  Test 1 NBB slope is y=16.01 
compared to the BB slope of y=8.62.  A similar difference in the steepness of 
the slope is seen in test 2 data with a NBB slope of y=17.8 and BB slope of 
y=9.19.  By using the %HRR means it takes away any effect for fitness.  The 
mean difference for the two groups shows a gradual increase in the 
difference in the intensity with a much greater difference between the %HRR 
at the final stage of the Chester step test where the intensity of the exercise 
is greatest. 
y = 9.19x + 14.4
y = 17.8x + 20.3
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
1 2 3 4
%
HR
R
Chester Step Test Stage
BB
NBB
33 
 
4.5 Analysis of RPE Data 
 
Fig 4.7 Test1 - Comparison of RPE at each stage of Chester Step Test 
 
 
Fig 4.8 Test 2- Comparison of RPE at each stage of Chester Step Test 
Table 4.6 Independent t-test findings for RPE at each stage of Chester Step Test 
 Stage1 Stage2 Stage3 Stage4 
Test 1 2 1 2 1 2 1 2 
BB 8.3±1.1 8.6±0.8 9.4±1.4 9.7±0.9 11±1.1 11±0.8 12.1±1.0 12±0.5 
NBB 9.1±0.9 9±0.9 10.8±1.7 10.6±1.7 12.1±1.7 11.9±1.3 13.5±0.9 13.3±1.3 
Difference 
mean 
0.8 0.4 1.4 0.9 1.1 0.9 1.4 1.3 
P VALUE P=0.018 P=0.154 P=0.008 P=0.041 P=0.022 P=0.002 P=0.002 P=0.000 
 
Figure 4.7 shows the steepness of the slopes between the BB and Non BB 
male participants RPE at each stage of the Chester Step Test.  The 
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steepness of the Non BB participants slope is greater than the Beta Blocked 
slope where y=1.45 and y=1.3 respectively. When looking at the mean 
differences between the groups at each stage of the test table 4.6 shows the 
mean difference between the groups RPE for each stage of the Chester Step 
test to be very similar as the intensity was increased.   Further analysis via 
the mixed model ANOVA revealed  a p value of p=>0.05, however as p=0.09 
it was decided to conduct the independent t test to see if there were any 
significant differences between the RPE in the groups across the stages.  
The t-test found significant differences between the RPEs of the two groups 
at all stages of the Chester Step test p=≤0.05. The t-test findings are 
summarised in table 4.6 
Figure 4.8 shows the steepness of the slopes between the BB and Non BB 
male participants RPE at each stage of the Chester Step Test.  The 
steepness of the Non BB participants slope is greater than the Beta Blocked 
slope where y=1.42 and y=1.15 respectively. When looking at the mean 
differences between the groups at each stage of the test table 4.6 shows a 
similar difference in the mean as the intensity of the exercise increased until 
the final stage where the difference between the means was greater. Further 
analysis via the mixed model ANOVA revealed significant differences exist 
between the groups data with p=≤0.05.  To find where the actual differences 
were between the groups independent t-test were run for each stage of the 
Chester Step test.  The t-test found significant differences between the RPEs 
of the two groups at stages 2-4 p=≤0.05.  No significant difference was found 
between the groups in stage 1 of the Chester Step test. The t-test findings 
are summarised in table 4.6. 
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4.6 Analysis of Male only RPE data 
 
 
Fig 4.9 Test 1 -Comparison of RPE at each stage of Chester Step Test for male 
participants  
 
 
Fig 4.10 Test 2- Comparison of RPE at each stage of Chester Step Test for male 
participants  
Table 4.7 Independent t-test findings for RPE at each stage of Chester Step Test 
 Stage1 Stage2 Stage3 Stage4 
Test 1 2 1 2 1 2 1 2 
BB 8.3±1.1 8.6±0.8 9.4±1.4 9.7±0.9 11±1.1 11±0.8 12.1±1.0 12±0.5 
NBB 9±0.9 9±0.9 10.7±2.1 10.7±2.2 12.2±1.3 11.5±1.4 13±0.7 13.2±1.5 
Difference 
 mean 
0.7 0.4 1.3 1.0 1.2 0.5 1.1 1.2 
P value P=0.394 P=0.304 P=0.089 P=0.107 P=0.061 P=0.176 P=0.136 P=0.003 
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Figure 4.9 shows the steepness of the slopes between the BB and Non BB 
male participants RPE at each stage of the Chester Step Test.  The 
steepness of the Non BB participants slope is greater than the Beta Blocked 
slope where y=1.44 and y=1.3 respectively. When looking at the mean 
differences between the groups at each stage of the test table 4.7 shows the 
mean difference between the groups RPE for each stage of the Chester Step 
test to be very similar as the intensity was increased   further analysis via the 
mixed model ANOVA revealed no significant differences exist between the 
groups data p=>0.05.   
Figure 4.10 shows the steepness of the slopes between the BB and Non BB 
male participants RPE at each stage of the Chester Step Test.  The 
steepness of the Non BB participants slope is greater than the Beta Blocked 
slope where y=1.34 and y=1.15 respectively. When looking at the mean 
differences between the groups at each stage of the test table 4.7 shows a 
similar difference in the mean as the intensity of the exercise increased 
through the stages similar to that seen in the trials comparing both the male 
and female data. Further analysis via the mixed model ANOVA revealed 
significant differences exist between the groups data p=≤0.05.  To find where 
the actual differences were between the groups independent t-test were run 
for each stage of the Chester Step test.  The T-test found a significant 
difference between the RPEs of the two groups in the final stage of the 
Chester Step test p=≤0.05.  The t-test findings are summarised in table 4.7 
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4.7 Limits of Agreement for Beta Blocked data 
Table 4.8 Limits of Agreement for Beta Blocked data over two tests. 95% L.o.A 
(expressed in bpm) (bias± 1.96xSDdiff) 
Stage of Chester Step Test 
 
 
LoA 
(HR- bpm) 
Stage 1 
 
1.8 ±3.5 
Stage 2 
 
2.8 ±5.5 
Stage 3 
 
2.7± 5.3 
Stage 4 
 
3.4 ±6.6 
Stage 5 
 
3.7 ±7.3 
 
When assessing reproducibility of HR between two trails of the CST the 95% 
L.o.A technique was used.  Table 4.8 shows the L.o.A for each stage of the 
CST.  Stage 1 worst case is 5bpm above or 2 bpm below the mean HR 
which would be considered an acceptable deviation in clinical practice.  
When the 5bpm is taken as a % difference this equates to 6% which at the 
lower end of exercise prescription is acceptable, as this is unlikely to cause 
any problems.  Stage 5 worst case is 11bpm above mean HR or 4bpm below 
which for the upper limit could be the difference between being at a patients 
ischemic threshold for which a patient with said threshold is advised to 
remain 10bpm below (ACSM) and is therefore much more clinically 
significant. When this is put as a % of the mean HR it equates to a 12% 
difference in the HR this difference could take a person at the upper limits of 
exercise to therefore exercising above current clinical exercise prescription 
guidelines.  
Table 4.9 Limits of Agreement  of RPE taken at each stage of Chester Step Test 
over 2 tests  
Stage of Chester Step Test 
 
 
LoA 
(RPE) 
Stage 1 
 
0.8 ±1.6 
Stage 2 
 
0.8 ±1.6 
Stage 3 
 
0.7 ±1.4 
Stage 4 
 
0.8 ±1.6 
Stage 5 
 
0.7 ±1.4 
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When looking at table 4.9 L.o.A for RPE, Stage 1 worst case is an RPE of 
2.4scale points above the mean which is not ideal in a clinical setting as this 
could be the difference between finding an exercise light to somewhat hard.  
Stage 5 worst case is an RPE of 2.1 scale points above the mean which at 
the upper ends of the RPE scale could be the difference between 15 and 17 
on the RPE scale. 
   
  
 
 
 
Fig 4.11 Individual Hr data for test 1 and test 2 (HR for test 1 is red line and test 2 
blue line.  HR is in Bpm on y axis and stage of CST is on x axis) 
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Figure 4.11 shows a close relationship between participants HR on test 1 
and test 2. With only participants 1, 18 and 20 showing any obvious 
difference between their HR at each stage of the CST on test 1 and test 2. 
 
 
Fig 4.12 Mean HR at each stage of Chester Step test for Beta Blocked participants 
for test 1 and test 2 
 
Figure 4.12 shows that the mean HR for participants over the two tests was 
identical for the final three stage with only slight elevation, in HR during 
stages 1and 2 of test 1 compared to test 2  This would suggest  a strong 
degree of reliability between the HR collected over the two tests. 
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Figure 4.15 shows 4 pieces of data outside the lower L.o.A for Stage 1 RPE 
data collected, suggesting an underestimation of RPE during test 1.  Figure 
4.16 shows the majority of data to eb around the mean with only one piece of 
data outside the 95% L.o.A. 
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5.0 Discussion 
 
5.1 Overview 
The study set out to assess the effect of BB on HR during incremental 
exercise and whether as the intensity of exercise was increased would the 
difference between BB and NBB HR responses increase.  The key finding 
here was there was a significant difference between the two groups HR at 
each stage of the CST P<0.05 therefore accepting the null hypothesis.  The 
second aim of the study was to assess if there was a difference in RPE 
ratings between the two groups during each stage of the CST.  The results 
found RPE was not affected by BB despite showing a significant difference 
between the two groups RPE. This difference can be almost discounted by 
the parallel trend lines between the two groups RPE response, implying the 
difference between the two groups is more likely to be fitness than the effect 
of the BB.  The final aim of the study was to assess the reliability of the CST 
in participants taking BB.  The study showed good reliability between the two 
tests with L.o.A suggesting a maximum HR deviation of 11 bpm at peak 
exercise. 
 
5.2 Heart Rate Analysis 
The main finding of the study was a less acute slope for BB participants HR 
response to incremental exercise compared to NBB participants HR 
response to the same incremental exercise.  The significant difference 
between the two groups HR through the t-test further confirms the difference 
between the two groups.  The significant difference between the two groups 
HR is in keeping with the known physiological effects of BB, namely of a 
lower HR on exertion (Head,1999).  The difference between the two groups 
HR was up to 25% or 20-30 bpm offering further support to the earlier 
findings of the effect of BB on HR compared to NBB HR by Van Hawaarden 
et al (1979), Pearson et al (1979), and Eston and Thompson (1997). When 
looking at the means of the two groups HR response, the difference between 
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the two groups at each stage of the CST increases as shown in table 4.4. 
The finding of an increase in the difference between the two groups and the 
non parallel slopes, contradicts the findings of Davies and Sargeant (1979) 
and Liu et al (2004), who suggested the HR relationship between BB and 
NBB during incremental exercise was a parallel one.  It is difficult to explain 
the difference between the two groups as anything other than the effects of 
the BB.  This statement is supported by the analysis of the HR response 
when %HRR is used instead of actual HR for the two groups at each stage of 
the CST.  Through looking at %HRR at each level of the CST it allows for 
varying fitness levels between the participants to be discounted.  The slopes 
between the two groups show the same relationship of an increase in the 
difference between the two groups as the intensity increases.  The slopes for 
the %HRR are in fact much steeper than the HR slopes; this finding could 
have the most implications on exercise prescription.   The findings of the BB 
mean %HRR at each stage of the CST are much lower than the current 
BACR, ACSM and AACVPR guidelines of 40-75%HRR.  The BB group peak 
%HRR was 51%±14 with a peak RPE of 12 ±1 compared to the NBB peak 
%HRR of 91%±22 with a peak RPE of 13.5 ±0.9.  This difference could of 
course be explained by the BB group being much fitter than the NBB 
participants.  The finding is in keeping with that of Wosnich et al.(2003) who 
questioned the effect of BB on percentage HR max and found that when BB 
are participants are encouraged to exercise at 85% MHR they may well be 
exercising above their anaerobic threshold.  This is something that would 
need much further investigation to offer an insight either way.  When these 
findings are also considered with the recent research by Roberg and 
Landwehr, (2002) and Tanaka et al. (2001), thoughts on determination of 
MHR via the traditional 220-age method and its considerable flaws in the 
older and clinical populations.  It further questions whether BB patients 
should have their own set of exercise prescription guidelines and not just the 
same set that are based on subjects not taking BB. 
Another explanation for the difference in the data could be the difference 
between male and female.  As all the BB data was males a comparison of 
HR at each stage of the CST was completed between males only from the 
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NBB group. Test 1 showed no difference in the steepness of the slopes, with 
the slopes running parallel as found by Davies and Sargeant (1979).  There 
was a significant difference between the actual HR of the two groups as to 
be expected due to the physiological effect of the BB. Test 2 for the male 
only data showed similar findings to that seen for the male and female data.  
The main difference was seen between the means for the males with an 
increase in the difference between the means only been seen at stage 4.  
This finding slightly questions the findings of the slopes for the BB male and 
female data combined.  However as the male only data is considerably 
different between the two tests, its evidence is inconclusive.  
5.3 RPE Analysis 
RPE findings between the two groups show a parallel relationship between 
RPE responses as intensity of exercise increases.  The mean difference 
between the two groups was only on average 1 scale point.  The finding of 
no effect of BB on RPE is in support of all previous findings of Pearson et 
al(1979), Eston and Connolly(1996) and Eston and Thompson (1997), who 
also found no effect of BB on subjects RPE rating during exercise.    Due to 
the lack of difference in the relationship between the two groups RPE 
response, it offers further support, that the findings of the HR difference were 
related to the effect of the BB rather than fitness of participants. RPE for the 
male only data showed the same trend lines as the male and female data, 
suggesting no difference between the male and females RPE responses 
which were suggested by Eston and Thompson (1997).  Eston and 
Thompson (1997) suggested that females had a tendency to over inflate their 
RPE rating for the same exercise level compared to male subjects. 
The RPE findings of this study are different from most research findings in 
that the lower RPE readings for each stage of the CST are from the BB 
group.  Eston and Thompson (1997) found in their study that not only 
females but those on BB had a tendency to over-inflate their RPE response.  
One possible explanation for this could again be the BB group were fitter 
than the NBB participants.  Another possibility could be that in this study all 
participants were taking the cardio-selective BB compared to research by 
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Pearson et al. (1979) who used the non-selective BB Propanolol.  Eston and 
Thompson (1997) stated cardio-selective BB is less likely to cause local 
muscle fatigue, compared to non-selective BB.  Localised muscle fatigue can 
affect a person’s perception of exercise.  This study also used participants 
who were well established on their BB treatment where as many previous 
studies have used healthy individuals as subjects, who were given a one off 
dose of BB.  The healthy participants in the studies may have overestimated 
their RPE due to the sudden physiological change they were experiencing 
due to the BB as found by Joyner et al.(1986)  The RPE findings however 
could be explained for the BB as being potentially overinflated for the %HRR 
found for the BB participants compared to that of the NBB subjects. 
 
5.4 Reproducibility of HR and RPE data on CST 
The L.o.A data supports Sykes (1998) statement that the CST doesn’t 
require a practice test.  The difference in HR data was at stage one only a 
maximum of five bpm, which could be put down to human error in data 
collection and is not in clinical context a major difference between HR.  The 
worst case difference in HR between the tests was up to 11bpm at stage 5 of 
the CST.  This again in a clinical context isn’t greatly significant considering 
the current recommended method for estimating MHR can be up to 20bpm 
above or below the initial figure obtained for an individual as stated by 
Roberg and Landwher (2002).  When this figure is taken as % of HR there 
could be a difference of up to 11%, which for any patients with the possibility 
for ischemia on exercise could make a major clinical difference.  The 
difference of 11% could potentially push a person into their ischemic or 
anaerobic threshold if they were exercising at the upper limits of exercise 
guidelines. 
The findings for reproducibility of RPE are the same as that of Buckley et al 
(2009) with the greatest difference in RPE being 2 scale points.  This finding 
supports the findings of Eston and Williams (1988) who also found excellent 
reliability for RPE between exercise sessions. 
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5.5Limitations to study 
It is worth highlighting that for the L.o.A analysis a sample size of 40 is 
recommended by Atkinson and Neville (1998) cited in Coakes and Steed 
(2007) as this allows for improved reliability.  Due to the time scale and the 
need to carry out 80 individual CST to achieve this sample size due to time 
constraints it was decided to halve the sample size. 
The BB data was only able to be collected in the time frame on male 
participants and as seen in the data analysis this can have an effect on the 
HR data. 
The data being compared in this study although completing the same test 
were conducted by different investigators.  Although protocols between the 
two groups are similar, it can’t be confirmed that the subjects underwent 
testing under the same conditions. 
 
5.6 Suggestions for future research 
The findings of this study generally supported the findings of previous 
studies.  There were however a few differences to previous studies that 
could be researched further.  The major difference between the two groups 
%HRR is an area which warrants further investigation as findings could have 
a long term effect on exercise prescription guidelines.  The findings from this 
study would suggest the possibility of a separate exercise intensity guide for 
BB patients. 
A larger sample size consisting of a full age range of Cardiac rehabilitation 
ages and incorporating both males and females on BB would allow for 
greater statistical power in findings and offer greater insight into some of the 
questions raised by this study of whether effects were purely related to BB or 
were there other possible contributing factors to the differences between the 
groups that were potentially masked due to the small specific sample size. 
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5.7 Conclusion 
In conclusion this study clearly shows a greater difference between HR for 
BB and NBB at the upper levels of exercise intensity that can only 
realistically be explained by the effects of BB on HR rather than any other 
factor. This finding could have an effect on exercise prescription using 
%HRR for BB as there is potential if using current guidelines to exercise 
patients above their ventilator threshold.  However this is a finding that needs 
considerable further research. 
 This study further adds to the growing body of research that RPE is 
unaffected by BB and that RPE is therefore a safe and practical tool to use 
for patients on BB to help guide their intensity within their exercise 
prescription. 
With the finding that RPE is unaffected by BB, and the effect of BB requiring 
further research, it highlights the importance of in a clinical context of using 
at least both HR and RPE to guide exercise intensity in patients taking BB.  
By using this dual approach to monitoring exercise it will help reduce the risk 
of patients exercising in their anaerobic threshold which could happen when 
HR alone is used to monitor exercise.  On the other side it can prevent 
patients not achieving appropriate levels of exercise for optimal physiological 
benefits which is still something to consider in particularly of the responses of 
females on BB. 
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What are the possible disadvantages and risks of taking part? 
 
It is possible when undertaking the test or after the test you may have some muscle discomfort in 
your legs. 
 
What are the possible benefits of taking part? 
 
There are no specific benefits for taking part, other than you will have a basic idea of your current 
level of fitness.  However the information obtained may contribute towards more effective ways 
of prescribing exercise for future cardiac rehabilitation patients.  
 
What if something goes wrong? 
 
If you wish to complain or have any concerns about any aspect of the way you have been 
approached or treated during the course of this study, please contact Professor Sarah Andrew, 
Dean of Faculty of Applied Sciences, University of Chester, Parkgate Road, Chester, CH1 4BJ, 
01244 513055 
 
Will my taking part in the study be kept confidential? 
 
All information which is collected about you during the course of the research will be kept strictly 
confidential so that only the researcher carrying out the study will have access to such 
information. 
 
What will happen to the results of the research study? 
 
The results will be written up in a report and possibly used for research publication.  Individuals 
who participate will not be identified in any subsequent report or publication. 
 
Who may I contact for further information? 
 
If you would like more information about the research before you decide whether or not you 
would be willing to take part please contact: 
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Protocol for Chester  Step Test 
This test is a submaximal test.  It is performed twice. Once at the first exercise 
session and repeated a week later. 
Equipment 
• Suitable room for testing. 
• A step of the required height (15cm) 
• Chester Step Test audio CD 
• CD player of sufficient power output that it can be clearly heard by the 
participant. 
• HR and RPE recording sheet 
• Polar Heart rate monitor 
• Rating of perceived exertion scale (RPE) 
Safety Equipment required 
• Defibrillator 
• Oxygen  
• Oxygen mask 
• Phone 
 
Method 
1. Participants will be health screened to ensure their suitability to perform the 
test. 
2. Baseline measurements will be taken for Blood pressure and polar heart rate 
monitor put on and  resting heart rate taken.. 
3. Participant will perform the test. 
Chester Step test 
1. Set up room, with CD player, and 15cm step. 
2. Explain to patient what is involved through each of the test and what 
measures will be taken at the end of each stage. 
3. To begin the test the patient stands in front of the step and when the CD 
starts the patients steps on and off the step to the beat set by the CD. 
4. At the end of each  2 minute stage ( maximum of 5 stages) the participants 
HR and RPE are recorded. 
5. The test is terminated when the participant achieves 80% of their maximal 
Heart rate (based on 220-age), they reach an RPE of 15(hard), they complete 
all 5 stages, or at a participants request to stop the test. 
 
